Clinical Evidence

Mammotome is committed to advancing breast care through evidence-based medicine. Trends in breast health change rapidly as technology evolves. Therefore, we’ve compiled the most relevant data for the solutions we offer as we continue to improve outcomes along the breast care continuum.

Style

Logo secondary background

MammoSTAR® Biopsy Site Marker

MammoSTAR^® Tissue Markers Case Study: Ultrasound Visibility at 60 Days

MammoSTAR^® Tissue Markers Case Study: Ultrasound Visibility

MammoSTAR® Tissue Markers Case Study: Ultrasound-Guided Wire Localization

MammoMARK® & CorMARK® Biopsy Site Identifier

MammoMARK^® Wire Localization

Mammotome® Elite

Comprehensive Review of Mammotome^® Elite

Utility of Adequate Core Biopsy Samples from Ultrasound Biopsies

Physicians Perspective on Mammotome^® Elite

Mammotome^® Elite Case Study: Small Lesions

Mammotome^® Elite Case Study: Microcalcifications

Mammotome^® Elite Case Study: Implant

Mammotome^® Elite Case Study: Enlarging Solid Mass

Mammotome^® Elite Case Study: Complex Cystic Mass

Mammotome^® Elite Case Study: Chest Wall Lesion

Mammotome^® Elite Case Study: Axillary Node Biopsy

Mammotome Revolve™

Adequate Core Biopsy Samples from Stereotactic Biopsies Needed for Today's Breast Pathology

Solution: Benign Lesion Excision

Minimal invasive complete excision of benign breast tumors using a three-dimensional ultrasound-guided Mammotome^® vacuum device

A comprehensive evaluation of 8-gauge vacuum-assisted Mammotome^® system for ultrasound-guided diagnostic biopsy and selective excision of breast lesions

Large volume ‘‘mammotome’’ biopsy may reduce the need for diagnostic surgery in papillary lesions of the breast

The Mammotome^® Biopsy System is an Effective Treatment Strategy for Breast Abscess

Vacuum-Assisted Core Biopsy in Diagnosis and Treatment of Intraductal Papillomas

Mammotome^® biopsy system for the resection of breast lesions

Style

Header-Colored,header-wide